Skip to main content
Toggle navigation
Services
Toggle sub-navigation
Mechanistic PK/PD
QSP/QST
PBPK
PopPK & E-R Analysis
Empirical PK/PD
MBMA
Clinical Pharmacology
AI/ML & Bioinformatics
Software
Toggle sub-navigation
Applied BioMath Assess™
Toggle sub-navigation
Cell Engager Model Pack
Biotherapeutic Model Pack
Gene Therapy Model Pack
Avidity Model Pack
Protein Degrader Model Pack
Solutions
Toggle sub-navigation
Early R&D
Preclinical Studies
Clinical Studies
Resources
Toggle sub-navigation
Our Science
Our Software
News
Events
About
Toggle sub-navigation
Our Team
Our Experience
Contact Us
Toggle Search
Enter your keywords
Breadcrumb
Home
Collaboration
Applied BioMath, LLC Announces Collaboration with Revitope for Mechanistic PK/PD Modeling in Solid Tumors
Read More
Collaboration
Applied BioMath, LLC Announces Collaboration with Sanofi for Systems Pharmacology Modeling of Bispecific Antibody Therapeutics
Read More
Collaboration
Applied BioMath, LLC announces collaboration with Sanofi for quantitative systems pharmacology modeling in immuno-oncology
Read More
Collaboration
Applied BioMath, LLC and CytomX Therapeutics, Inc. Announce a Continuation of their Collaboration for Quantitative Systems Pharmacology Modeling in Immuno-Oncology
Read More
Events
Registration is Open for [Webinar] Quantitative Modeling and Simulation Approaches: Driving Critical Decisions from Research through Clinical Trials
Read More
News
Applied BioMath, LLC awarded grant by National Institute on Aging of the NIH for the development of a systems pharmacology model in Alzheimer's Disease and Dementia
Read More
Events
Applied BioMath, LLC to Present at the Annual Drug Development Boot Camp
Read More
Events
Applied BioMath, LLC Announces Participation at PEGS: The Essential Protein Engineering Summit
Read More
Collaboration
Applied BioMath, LLC Announces Collaboration with Checkpoint Therapeutics for Semi-Mechanistic Pharmacokinetic and Pharmacodynamic Modeling in Immuno-Oncology
Read More
Collaboration
Applied BioMath, LLC Collaborates with Xencor for Semi-Mechanistic PK/PD Modeling of XmAb®24306, Xencor's Lead IL15 Program for the Treatment of Solid Tumors
Read More
Pagination
First
Previous
…
Page
3
Page
4
Page
5
Page
6
Current page
7
Page
8
Page
9
Page
10
Page
11
…
Next
Last
Subscribe to
Top